We use cookies for a better user experience. Read our Privacy Policy

I Agree

Pediatric Health Care Products and Services Market

Pediatric Health Care Products and Services Market (Drug Class - Antibiotics, Analgesics, Anti-asthmatics, Antidepressants, Antidiarrheal, Antifungal, Anti-histamines, Antihypertensives, Anti-metabolites, Anti-neoplastic Antibiotics, Antipsychotics; Disease/Disorder - Allergy and Respiratory, Cancer, Cardiovascular, Central Nervous System, Gastrointestinal, Hormonal Imbalance, Infections; Service Type - Child Psychiatry Services, Gastrointestinal Services, Pediatric Cancer Services, Pediatric Diabetes Services, Pediatric Heart Services) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Global Pediatric Health Care Products and Services Market - Snapshot

Pediatrics is a branch of medicine which deals with the health, growth, and development of infants, children, and adolescents. According to the report, the global pediatric health care products and services market was valued at around US$ 88,000 Mn and US$ 520,000 Mn, respectively, in 2017 and is projected to expand at a CAGR of around 4.5% and 5.5%, respectively, from 2018 to 2026. Unhealthy lifestyle habits and rise in obese pediatric population propel the pediatric health care products and services market. The world is going through a rapid nutritional and epidemiological shift, rise in prevalence of obesity, cardiovascular disease, nutrition-related chronic diseases, and cancer. Changes in lifestyle, for instance, in eating habits, have led to an increase in obesity.

Obesity is a growing problem in developed as well as in developing countries. Obese or overweight children are likely to remain obese in their adulthood and are susceptible to non-communicable diseases, such as cardiovascular diseases and diabetes, at a younger age. According to a study conducted by the World Health Organization (WHO), in 2016 the number of overweight children, under the age of five, was estimated at more than 41 million globally. Almost half of all overweight children under five years of age lived in Asia and one quarter lived in Africa.

pediatric-health-care-products-services-market.jpg

Launch of new drugs by pharmaceutical companies for pediatric patients and increase in focus by global research bodies on the development of new and improved drugs for children are expected to drive the pediatric therapeutics market during the forecast period. Rise in prevalence of diseases and disorders such as allergies, asthma, mental disorders, diabetes, infectious diseases among children and increase in awareness regarding these diseases among parents boost the pediatric services market. Rise in patient pool and increase in government efforts to raise awareness regarding pediatric disorders and treatments have created opportunities for players operating in the market.

The global pediatric health care products and services market has been analyzed based on drug class, disease/ disorder, services type, and region. In terms of drug class, the antibiotics segment is anticipated accounted for the largest share of the market in 2017 and its share is projected to increase by 2026. Antibiotics are extensively utilized, particularly for pediatric patients, due to their efficacy in treating bacterial infections. Based on disease/disorder, the allergy and respiratory segment is expected to account for a large share of the market. The segment is projected to expand at a CAGR more than 4.5% during the forecast period. Expansion of the segment can be attributed to the rise in demand for pediatric health care products for allergy and respiratory disorders. Among pediatric services types, the others services segment includes communicable diseases, non-communicable diseases, neonetal disorders, respiratory disorders, neurosurgical, and musculoskeletal services is expected to dominate the market. The others segment is expected to account for more than 60% share of the market by 2026.

Based on region, North America accounted for a dominant share of the global pediatric health care products and services market in 2017. The region accounted for a substantial share of the market due to launch of new drugs by pharmaceutical companies for pediatric patients in the region. The market in Asia Pacific is projected to expand at a considerable growth rate during the forecast period due to the increase in number of children with diseases and disorders and improvement in the health care infrastructure in countries such as China, India, and Indonesia.

Key players operating in the market include Pfizer Inc., GlaxoSmithKline plc. Merck & Co., Inc, AstraZeneca plc., Boehringer Ingelheim GmbH, Gilead Sciences, Inc., Sanofi S.A., Pediapharm, Inc., Novartis AG, Eisai Co., Ltd., and Mylan N.V. These players focus on R&D activities to develop and launch innovative product line in the market. For instance, in July 2017, Eisai Co., Ltd. received the U.S. Food and Drug Administration approval for its new product Fycompa, used to treat partial-onset seizures (POS). Moreover, in January 2017, Pediapharm, Inc. launched Rupall for the symptomatic relief of nasal and non-nasal symptoms of seasonal allergic rhinitis.

The global pediatric health care products and services market is segmented as given below:

Drug Class

  • Antibiotics
  • Analgesics
  • Anti-asthmatics
  • Antidepressants
  • Antidiarrheal
  • Antifungal
  • Anti-histamines
  • Antihypertensives
  • Anti-metabolites
  • Anti-neoplastic Antibiotics
  • Antipsychotics
  • Others

Disease/Disorder

  • Allergy and Respiratory
  • Cancer
  • Cardiovascular
  • Central Nervous System
  • Gastrointestinal
  • Hormonal Imbalance
  • Infections
  • Others

Services

  • Child Psychiatry Services
  • Gastrointestinal Services
  • Pediatric Cancer Services
  • Pediatric Diabetes Services
  • Pediatric Heart Services
  • Others

Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Israel
    • Rest of MEA
Pediatric Health Care Products and Services Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Pediatric Health Care Products and Services Market

4. Market Overview
     4.1. Introduction
            4.1.1. Disorder/Disease Definition
            4.1.2. Industry Evolution/Developments
     4.2. Overview
     4.3. Market Dynamics
            4.3.1. Drivers
            4.3.2. Restraints
            4.3.3. Opportunities
     4.4. Global Pediatric Health Care Products and Services Market Analysis and Forecasts, 2016–2026
            4.4.1. Market Revenue Projections, by Product Type (US$ Mn)
            4.4.2. Market Revenue Projections, by Services Type (US$ Mn)

5. Market Overview
     5.1. Clinical Trial Analysis
     5.2. Disease Incidence and Prevalence
     5.3. Regulatory Framework

6. Global Pediatric Health Care Products and Services Market Analysis and Forecasts, by Disorder/Disease
     6.1. Introduction & Definition
     6.2. Key Findings/Developments
     6.3. Market Value Forecast by Disorder/Disease, 2016–2026
            6.3.1. Allergy and Respiratory
            6.3.2. Cancer
            6.3.3. Cardiovascular
            6.3.4. Central Nervous System
            6.3.5. Gastrointestinal
            6.3.6. Hormonal Imbalance
            6.3.7. Infections
            6.3.8. Others
     6.4. Market Attractiveness by Disorder/Disease

7. Global Pediatric Health Care Products and Services Market Analysis and Forecasts, by Drug Class
     7.1. Introduction & Definition
     7.2. Key Findings/Developments
     7.3. Market Value Forecast by Drug Class, 2016–2026
            7.3.1. Antibiotics
            7.3.2. Analgesics
            7.3.3. Anti-asthmatics
            7.3.4. Antidepressants
            7.3.5. Antidiarrheal
            7.3.6. Antifungal
            7.3.7. Anti-histamines
            7.3.8. Antihypertensives
            7.3.9. Anti-metabolites
            7.3.10. Anti-neoplastic Antibiotics
            7.3.11. Antipsychotics
            7.3.12. Others

8. Global Pediatric Health Care Products and Services Market Analysis and Forecasts, by Services
     8.1. Introduction & Definition
     8.2. Key Findings/Developments
     8.3. Market Value Forecast by Services, 2016–2026
            8.3.1. Child Psychiatry Services
            8.3.2. Gastrointestinal Services
            8.3.3. Pediatric Cancer Services
            8.3.4. Pediatric Diabetes Services
            8.3.5. Pediatric Heart Services
            8.3.6. Others

9. Global Pediatric Health Care Products and Services Market Analysis and Forecasts, by Region
     9.1. Key Findings
     9.2. Market Value Forecast by Region
            9.2.1. North America
            9.2.2. Europe
            9.2.3. Asia Pacific
            9.2.4. Latin America
            9.2.5. Middle East & Africa
     9.3. Market Attractiveness by Country/Region

10. North America Pediatric Health Care Products and Services Market Analysis and Forecast
     10.1. Introduction
            10.1.1. Key Findings
     10.2. Market Value Forecast by Disorder/Disease, 2016–2026
            10.2.1. Allergy and Respiratory
            10.2.2. Cancer
            10.2.3. Cardiovascular
            10.2.4. Central Nervous System
            10.2.5. Gastrointestinal
            10.2.6. Hormonal Imbalance
            10.2.7. Infections
            10.2.8. Others
     10.3. Market Value Forecast by Drug Class, 2016–2026
            10.3.1. Antibiotics
            10.3.2. Analgesics
            10.3.3. Anti-asthmatics
            10.3.4. Antidepressants
            10.3.5. Antidiarrheal
            10.3.6. Antifungal
            10.3.7. Anti-histamines
            10.3.8. Antihypertensives
            10.3.9. Anti-metabolites
            10.3.10. Anti-neoplastic Antibiotics
            10.3.11. Antipsychotics
            10.3.12. Others
     10.4. Market Value Forecast by Services, 2016–2026
            10.4.1. Child Psychiatry Services
            10.4.2. Gastrointestinal Services
            10.4.3. Pediatric Cancer Services
            10.4.4. Pediatric Diabetes Services
            10.4.5. Pediatric Heart Services
            10.4.6. Others
     10.5. Market Value Forecast by Country, 2016–2026
            10.5.1. U.S.
            10.5.2. Canada
     10.6. Market Attractiveness Analysis
            10.6.1. By Disorder/Disease
            10.6.2. By Drug Class
            10.6.3. By Services
            10.6.4. By Country

11. Europe Pediatric Health Care Products and Services Market Analysis and Forecast
     11.1. Introduction
            11.1.1. Key Findings
     11.2. Market Value Forecast by Disorder/Disease, 2016–2026
            11.2.1. Allergy and Respiratory
            11.2.2. Cancer
            11.2.3. Cardiovascular
            11.2.4. Central Nervous System
            11.2.5. Gastrointestinal
            11.2.6. Hormonal Imbalance
            11.2.7. Infections
            11.2.8. Others
     11.3. Market Value Forecast by Drug Class, 2016–2026
            11.3.1. Antibiotics
            11.3.2. Analgesics
            11.3.3. Anti-asthmatics
            11.3.4. Antidepressants
            11.3.5. Antidiarrheal
            11.3.6. Antifungal
            11.3.7. Anti-histamines
            11.3.8. Antihypertensives
            11.3.9. Anti-metabolites
            11.3.10. Anti-neoplastic Antibiotics
            11.3.11. Antipsychotics
            11.3.12. Others
     11.4. Market Value Forecast by Services, 2016–2026
            11.4.1. Child Psychiatry Services
            11.4.2. Gastrointestinal Services
            11.4.3. Pediatric Cancer Services
            11.4.4. Pediatric Diabetes Services
            11.4.5. Pediatric Heart Services
            11.4.6. Others
     11.5. Market Value Forecast by Country, 2016–2026
            11.5.1. Germany
            11.5.2. U.K.
            11.5.3. France
            11.5.4. Spain
            11.5.5. Italy
            11.5.6. Rest of Europe
     11.6. Market Attractiveness Analysis
            11.6.1. By Disorder/Disease
            11.6.2. By Drug Class
            11.6.3. By Services
            11.6.4. By Country

12. Asia Pacific Pediatric Health Care Products and Services Market Analysis and Forecast
     12.1. Introduction
            12.1.1. Key Findings
     12.2. Market Value Forecast by Disorder/Disease, 2016–2026
            12.2.1. Allergy and Respiratory
            12.2.2. Cancer
            12.2.3. Cardiovascular
            12.2.4. Central Nervous System
            12.2.5. Gastrointestinal
            12.2.6. Hormonal Imbalance
            12.2.7. Infections
            12.2.8. Others
     12.3. Market Value Forecast by Drug Class, 2016–2026
            12.3.1. Antibiotics
            12.3.2. Analgesics
            12.3.3. Anti-asthmatics
            12.3.4. Antidepressants
            12.3.5. Antidiarrheal
            12.3.6. Antifungal
            12.3.7. Anti-histamines
            12.3.8. Antihypertensives
            12.3.9. Anti-metabolites
            12.3.10. Anti-neoplastic Antibiotics
            12.3.11. Antipsychotics
            12.3.12. Others
     12.4. Market Value Forecast by Services, 2016–2026
            12.4.1. Child Psychiatry Services
            12.4.2. Gastrointestinal Services
            12.4.3. Pediatric Cancer Services
            12.4.4. Pediatric Diabetes Services
            12.4.5. Pediatric Heart Services
            12.4.6. Others
     12.5. Market Value Forecast by Country, 2016–2026
            12.5.1. China
            12.5.2. Japan
            12.5.3. India
            12.5.4. Australia & New Zealand
            12.5.5. Rest of Asia Pacific
     12.6. Market Attractiveness Analysis
            12.6.1. By Disorder/Disease
            12.6.2. By Drug Class
            12.6.3. By Services
            12.6.4. By Country

13. Latin America Pediatric Health Care Products and Services Market Analysis and Forecast
     13.1. Introduction
            13.1.1. Key Findings
     13.2. Market Value Forecast by Disorder/Disease, 2016–2026
            13.2.1. Allergy and Respiratory
            13.2.2. Cancer
            13.2.3. Cardiovascular
            13.2.4. Central Nervous System
            13.2.5. Gastrointestinal
            13.2.6. Hormonal Imbalance
            13.2.7. Infections
            13.2.8. Others
     13.3. Market Value Forecast by Drug Class, 2016–2026
            13.3.1. Antibiotics
            13.3.2. Analgesics
            13.3.3. Anti-asthmatics
            13.3.4. Antidepressants
            13.3.5. Antidiarrheal
            13.3.6. Antifungal
            13.3.7. Anti-histamines
            13.3.8. Antihypertensives
            13.3.9. Anti-metabolites
            13.3.10. Anti-neoplastic Antibiotics
            13.3.11. Antipsychotics
            13.3.12. Others
     13.4. Market Value Forecast by Services, 2016–2026
            13.4.1. Child Psychiatry Services
            13.4.2. Gastrointestinal Services
            13.4.3. Pediatric Cancer Services
            13.4.4. Pediatric Diabetes Services
            13.4.5. Pediatric Heart Services
            13.4.6. Others
     13.5. Market Value Forecast by Country, 2016–2026
            13.5.1. Brazil
            13.5.2. Mexico
            13.5.3. Rest of Latin America
     13.6. Market Attractiveness Analysis
            13.6.1. By Disorder/Disease
            13.6.2. By Drug Class
            13.6.3. By Services
            13.6.4. By Country

14. Middle East & Africa Pediatric Health Care Products and Services Market Analysis and Forecast
     14.1. Introduction
            14.1.1. Key Findings
     14.2. Market Value Forecast by Disorder/Disease, 2016–2026
            14.2.1. Allergy and Respiratory
            14.2.2. Cancer
            14.2.3. Cardiovascular
            14.2.4. Central Nervous System
            14.2.5. Gastrointestinal
            14.2.6. Hormonal Imbalance
            14.2.7. Infections
            14.2.8. Others
     14.3. Market Value Forecast by Drug Class, 2016–2026
            14.3.1. Antibiotics
            14.3.2. Analgesics
            14.3.3. Anti-asthmatics
            14.3.4. Antidepressants
            14.3.5. Antidiarrheal
            14.3.6. Antifungal
            14.3.7. Anti-histamines
            14.3.8. Antihypertensives
            14.3.9. Anti-metabolites
            14.3.10. Anti-neoplastic Antibiotics
            14.3.11. Antipsychotics
            14.3.12. Others
     14.4. Market Value Forecast by Services, 2016–2026
            14.4.1. Child Psychiatry Services
            14.4.2. Gastrointestinal Services
            14.4.3. Pediatric Cancer Services
            14.4.4. Pediatric Diabetes Services
            14.4.5. Pediatric Heart Services
            14.4.6. Others
     14.5. Market Value Forecast by Country, 2016–2026
            14.5.1. GCC Countries
            14.5.2. South Africa
            14.5.3. Israel
            14.5.4. Rest of Middle East & Africa
     14.6. Market Attractiveness Analysis
            14.6.1. By Disorder/Disease
            14.6.2. By Drug Class
            14.6.3. By Services
            14.6.4. By Country

15. Competition Landscape
     15.1. Market Player – Competition Matrix (by Tier and Size of companies)
     15.2. Company Profiles
            15.2.1. AstraZeneca plc
                     15.2.1.1. Overview (HQ, Employee Strength, Business Segments)
                     15.2.1.2. Financials
                     15.2.1.3. Recent Development
                     15.2.1.4. Strategy
            15.2.2. Boehringer Ingelheim GmbH
                     15.2.2.1. Overview (HQ, Employee Strength, Business Segments)
                     15.2.2.2. Financials
                     15.2.2.3. Recent Development
                     15.2.2.4. Strategy
            15.2.3. Eisai Co., Ltd.
                     15.2.3.1. Overview (HQ, Employee Strength, Business Segments)
                     15.2.3.2. Financials
                     15.2.3.3. Recent Development
                     15.2.3.4. Strategy
            15.2.4. Gilead Sciences, Inc.
                     15.2.4.1. Overview (HQ, Employee Strength, Business Segments)
                     15.2.4.2. Financials
                     15.2.4.3. Recent Development
                     15.2.4.4. Strategy
            15.2.5. GlaxoSmithKline plc
                     15.2.5.1. Overview (HQ, Employee Strength, Business Segments)
                     15.2.5.2. Financials
                     15.2.5.3. Recent Development
                     15.2.5.4. Strategy
            15.2.6. Merck & Co., Inc.
                     15.2.6.1. Overview (HQ, Employee Strength, Business Segments)
                     15.2.6.2. Financials
                     15.2.6.3. Recent Development
                     15.2.6.4. Strategy
            15.2.7. Mylan N.V.
                     15.2.7.1. Overview (HQ, Employee Strength, Business Segments)
                     15.2.7.2. Financials
                     15.2.7.3. Recent Development
                     15.2.7.4. Strategy
            15.2.8. Novartis AG
                     15.2.8.1. Overview (HQ, Employee Strength, Business Segments)
                     15.2.8.2. Financials
                     15.2.8.3. Recent Development
                     15.2.8.4. Strategy
            15.2.9. Pediapharm, Inc.
                     15.2.9.1. Overview (HQ, Employee Strength, Business Segments)
                     15.2.9.2. Financials
                     15.2.9.3. Recent Development
                     15.2.9.4. Strategy
            15.2.10. Pfizer Inc.
                     15.2.10.1. Overview (HQ, Employee Strength, Business Segments)
                     15.2.10.2. Financials
                     15.2.10.3. Recent Development
                     15.2.10.4. Strategy
            15.2.11. Sanofi S.A.
                     15.2.11.1. Overview (HQ, Employee Strength, Business Segments)
                     15.2.11.2. Financials
                     15.2.11.3. Recent Development
                     15.2.11.4. Strategy

List of Tables

Table 01: Global Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Disorder/Disease, 2016–2026
Table 02: Global Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 03: Global Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Service Type, 2016–2026
Table 04: Global Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 05: Global Pediatric Health Care Services Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 06: North America Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 07: North America Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 08: North America Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Disorder/Disease, 2016–2026
Table 09: North America Pediatric Health Care Services Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 10: North America Pediatric Health Care Services Market Size (US$ Mn) Forecast, by Service type, 2016–2026
Table 11: Europe Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 12: Europe Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 13: Europe Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Disorder/Disease, 2016–2026
Table 14: Europe Pediatric Health Care Services Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 15: Europe Pediatric Health Care Services Market Size (US$ Mn) Forecast, by Services Type, 2016–2026
Table 16: Asia Pacific Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 17: Asia Pacific Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 18: Asia Pacific Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Disorder/Disease, 2016–2026
Table 19: Asia Pacific Pediatric Health Care Services Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 20: Asia Pacific Pediatric Health Care Services Market Size (US$ Mn) Forecast, by Services Type, 2016–2026
Table 21: Latin America Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 22: Latin America Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 23: Latin America Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Disorder/Disease, 2016–2026
Table 24: Latin America Pediatric Health Care Services Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 25: Latin America Pediatric Health Care Services Market Size (US$ Mn) Forecast, by Service Type, 2016–2026
Table 26: Middle East & Africa Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 27: Middle East & Africa Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 28: Middle East & Africa Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Disorder/Disease, 2016–2026
Table 29: Middle East & Africa Pediatric Health Care Services Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 30: Middle East & Africa Pediatric Health Care Services Market Size (US$ Mn) Forecast, by Service Type, 2016–2026

List of Figures

Figure 01: Global Pediatric Health Care Products Market Size (US$ Mn) Forecast, 2018–2026
Figure 02: Global Pediatric Health Care Services Market Size (US$ Mn) Forecast, 2018–2026
Figure 03: Global Pediatric Health Care Products and Services Market Value Share Analysis, by Disorder/Disease, 2017 and 2026
Figure 04: Global Pediatric Health Care Products and Services Market Size (US$ Mn) and Y-o-Y Growth, by Allergy and Respiratory Market Revenue, 2016–2026
Figure 05: Global Pediatric Health Care Products and Services Market Size (US$ Mn) and Y-o-Y Growth, by Cancer Market Revenue, 2016–2026
Figure 06: Global Pediatric Health Care Products and Services Market Size (US$ Mn) and Y-o-Y Growth, by Cardiovascular Market Revenue, 2016–2026
Figure 07: Global Pediatric Health Care Products and Services Market Size (US$ Mn) and Y-o-Y Growth, by Central Nervous System Market Revenue, 2016–2026
Figure 08: Global Pediatric Health Care Products and Services Market Size (US$ Mn) and Y-o-Y Growth, by Gastrointestinal Market Revenue, 2016–2026
Figure 09: Global Pediatric Health Care Products and Services Market Size (US$ Mn) and Y-o-Y Growth, by Hormonal Imbalance Market Revenue, 2016–2026
Figure 10: Global Pediatric Health Care Products and Services Market Size (US$ Mn) and Y-o-Y Growth, by Infections Market Revenue, 2016–2026
Figure 11: Global Pediatric Health Care Products and Services Market Size (US$ Mn) and Y-o-Y Growth, by Others Market Revenue, 2016–2026
Figure 12: Global Pediatric Health Care Products and Services Market Attractiveness Analysis, by Disorder/Disease
Figure 13: Global Pediatric Health Care Products and Services Market Value Share Analysis, by Drug Class, 2017 and 2026
Figure 14: Global Antibiotics Market Revenue, US$ Mn, 2018–2026
Figure 15: Global Analgesics Market Revenue, US$ Mn, 2018–2026
Figure 16: Global Anti-asthmatics Market Revenue, US$ Mn, 2018–2026
Figure 17: Global Antidepressants Market Revenue, US$ Mn, 2018–2026
Figure 18: Global Antidiarrheal Market Revenue, US$ Mn, 2018–2026
Figure 19: Global Antifungal Market Revenue, US$ Mn, 2018–2026
Figure 20: Global Anti-histamines Market Revenue, US$ Mn, 2018–2026
Figure 21: Global Antihypertensives Market Revenue, US$ Mn, 2018–2026
Figure 22: Global Anti-metabolites Market Revenue, US$ Mn, 2018–2026
Figure 23: Global Anti-neoplastic Antibiotics Market Revenue, US$ Mn, 2018–2026
Figure 24: Global Antipsychotics Market Revenue, US$ Mn, 2018–2026
Figure 25: Global Other Drug Class Market Revenue, US$ Mn, 2018–2026
Figure 26: Global Pediatric Health Care Products and Services Market Attractiveness Analysis, by Drug Class
Figure 27: Global Pediatric Health Care Products and Services Market Value Share Analysis, by Service Type, 2017 and 2026
Figure 28: Global Pediatric Health Care Products and Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Child Psychiatry Services, 2018–2026
Figure 29: Global Pediatric Health Care Products and Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Gastrointestinal Services, 2018–2026
Figure 30: Global Pediatric Health Care Products and Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pediatric Cancer Services, 2018–2026
Figure 31: Global Pediatric Health Care Products and Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pediatric Diabetes Services, 2018–2026
Figure 32: Global Pediatric Health Care Products and Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pediatric Heart Services, 2018–2026
Figure 33: Global Pediatric Health Care Products and Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2018–2026
Figure 34: Global Pediatric Health Care Products and Services Market Attractiveness Analysis, by Service Type
Figure 35: Global Pediatric Health Care Products Market Value Share Analysis, by Region, 2016 and 2025
Figure 36: Global Pediatric Health Care Products Market Attractiveness Analysis, by Region
Figure 37: Global Pediatric Health Care Services Market Value Share Analysis, by Region, 2016 and 2025
Figure 38: Global Pediatric Health Care Services Market Attractiveness Analysis, by Region
Figure 39: North America Pediatric Health Care Products Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
Figure 40: North America Pediatric Health Care Products Market Value Share, by Country, 2017 and 2026
Figure 41: North America Pediatric Health Care Products Market Attractiveness, by Country, 2018–2026
Figure 42: North America Pediatric Health Care Products Market Value Share, by Drug Class, 2017 and 2026
Figure 43: North America Pediatric Health Care Products Market Attractiveness, by Drug Class, 2018–2026
Figure 44: North America Pediatric Health Care Products Market Value Share Analysis, by Disorder/Disease
Figure 45: North America Pediatric Health Care Products Market Attractiveness, by Disorder/Disease, 2018–2026
Figure 46: North America Pediatric Health Care Services Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
Figure 47: North America Pediatric Health Care Services Market Value Share, by Country, 2017 and 2026
Figure 48: North America Pediatric Health Care Services Market Attractiveness, by Country, 2018–2026
Figure 49: North America Pediatric Health Care Services Market Value Share, by Service type, 2017 and 2026
Figure 50: North America Pediatric Health Care Services Market Attractiveness, by Service type, 2018–2026
Figure 51: Europe Pediatric Health Care Products Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
Figure 52: Europe Pediatric Health Care Products Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 53: Europe Pediatric Health Care Products Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 54: Europe Pediatric Health Care Products Market Value Share, by Drug Class, 2017 and 2026
Figure 55: Europe Pediatric Health Care Products Market Attractiveness, by Drug Class, 2018–2026
Figure 56: Europe Pediatric Health Care Products Market Value Share Analysis, by Disorder/Disease
Figure 57: Europe Pediatric Health Care Products Market Attractiveness, by Disorder/Disease, 2018–2026
Figure 58: Europe Pediatric Health Care Services Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
Figure 59: Europe Pediatric Health Care Services Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 60: Europe Pediatric Health Care Services Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 61: Europe Pediatric Health Care Services Market Value Share, by Services Type, 2017 and 2026
Figure 62: Europe Pediatric Health Care Services Market Attractiveness, by Services Type, 2018–2026
Figure 63: Asia Pacific Pediatric Health Care Products Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
Figure 64: Asia Pacific Pediatric Health Care Products Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 65: Asia Pacific Pediatric Health Care Products Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 66: Asia Pacific Pediatric Health Care Products Market Value Share, by Drug Class, 2017 and 2026
Figure 67: Asia Pacific Pediatric Health Care Products Market Attractiveness, by Drug Class, 2018–2026
Figure 68: Asia Pacific Pediatric Health Care Products Market Value Share Analysis, by Disorder/Disease
Figure 69: Asia Pacific Pediatric Health Care Products Market Attractiveness, by Disorder/Disease, 2018–2026
Figure 70: Asia Pacific Pediatric Health Care Services Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
Figure 71: Asia Pacific Pediatric Health Care Services Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 72: Asia Pacific Pediatric Health Care Services Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 73: Asia Pacific Pediatric Health Care Services Market Value Share, by Services Type, 2017 and 2026
Figure 74: Asia Pacific Pediatric Health Care Services Market Attractiveness, by Services Type, 2018–2026
Figure 75: Latin America Pediatric Health Care Products Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 76: Latin America Pediatric Health Care Products Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 77: Latin America Pediatric Health Care Products Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 78: Latin America Pediatric Health Care Products Market Value Share, by Drug Class, 2017 and 2026
Figure 79: Latin America Pediatric Health Care Products Market Attractiveness, by Drug Class, 2018–2026
Figure 80: Latin America Pediatric Health Care Products Market Value Share Analysis, by Disorder/Disease
Figure 81: Latin America Pediatric Health Care Products Market Attractiveness, by Disorder/Disease, 2018–2026
Figure 82: Latin America Pediatric Health Care Services Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 83: Latin America Pediatric Health Care Services Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 84: Latin America Pediatric Health Care Services Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 85: Latin America Pediatric Health Care Services Market Value Share, by Service Type, 2017 and 2026
Figure 86: Latin America Pediatric Health Care Services Market Attractiveness, by Service Type, 2018–2026
Figure 87: Middle East & Africa Pediatric Health Care Products Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 88: Middle East & Africa Pediatric Health Care Products Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 89: Middle East & Africa Pediatric Health Care Products Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 90: Middle East & Africa Pediatric Health Care Products Market Value Share, by Drug Class, 2017 and 2026
Figure 91: Middle East & Africa Pediatric Health Care Products Market Attractiveness, by Drug Class, 2018–2026
Figure 92: Middle East & Africa Pediatric Health Care Products Market Value Share Analysis, by Disorder/Disease
Figure 93: Middle East & Africa Pediatric Health Care Products Market Attractiveness, by Disorder/Disease, 2018–2026
Figure 94: Middle East & Africa Pediatric Health Care Services Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 95: Middle East & Africa Pediatric Health Care Services Market Value Share, by Country, 2017 and 2026
Figure 96: Middle East & Africa Pediatric Health Care Services Market Attractiveness, by Country, 2018–2026
Figure 97: Middle East & Africa Pediatric Health Care Services Market Value Share, by Service Type, 2017 and 2026
Figure 98: Middle East & Africa Pediatric Health Care Services Market Attractiveness, by Service Type, 2018–2026

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

170

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved